Correlation Between NYSE Composite and Adverum Biotechnologies
Can any of the company-specific risk be diversified away by investing in both NYSE Composite and Adverum Biotechnologies at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining NYSE Composite and Adverum Biotechnologies into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between NYSE Composite and Adverum Biotechnologies, you can compare the effects of market volatilities on NYSE Composite and Adverum Biotechnologies and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in NYSE Composite with a short position of Adverum Biotechnologies. Check out your portfolio center. Please also check ongoing floating volatility patterns of NYSE Composite and Adverum Biotechnologies.
Diversification Opportunities for NYSE Composite and Adverum Biotechnologies
0.07 | Correlation Coefficient |
Significant diversification
The 3 months correlation between NYSE and Adverum is 0.07. Overlapping area represents the amount of risk that can be diversified away by holding NYSE Composite and Adverum Biotechnologies in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Adverum Biotechnologies and NYSE Composite is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on NYSE Composite are associated (or correlated) with Adverum Biotechnologies. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Adverum Biotechnologies has no effect on the direction of NYSE Composite i.e., NYSE Composite and Adverum Biotechnologies go up and down completely randomly.
Pair Corralation between NYSE Composite and Adverum Biotechnologies
Assuming the 90 days trading horizon NYSE Composite is expected to generate 0.17 times more return on investment than Adverum Biotechnologies. However, NYSE Composite is 6.0 times less risky than Adverum Biotechnologies. It trades about 0.26 of its potential returns per unit of risk. Adverum Biotechnologies is currently generating about -0.19 per unit of risk. If you would invest 1,945,669 in NYSE Composite on August 30, 2024 and sell it today you would earn a total of 75,313 from holding NYSE Composite or generate 3.87% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Insignificant |
| Accuracy | 100.0% |
| Values | Daily Returns |
NYSE Composite vs. Adverum Biotechnologies
Performance |
| Timeline |
NYSE Composite and Adverum Biotechnologies Volatility Contrast
Predicted Return Density |
| Returns |
NYSE Composite
Pair trading matchups for NYSE Composite
Adverum Biotechnologies
Pair trading matchups for Adverum Biotechnologies
Pair Trading with NYSE Composite and Adverum Biotechnologies
The main advantage of trading using opposite NYSE Composite and Adverum Biotechnologies positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if NYSE Composite position performs unexpectedly, Adverum Biotechnologies can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Adverum Biotechnologies will offset losses from the drop in Adverum Biotechnologies' long position.| NYSE Composite vs. Delek Drilling | NYSE Composite vs. Helmerich and Payne | NYSE Composite vs. Waste Management | NYSE Composite vs. US Global Investors |
| Adverum Biotechnologies vs. Uniqure NV | Adverum Biotechnologies vs. Rocket Pharmaceuticals | Adverum Biotechnologies vs. Rhythm Pharmaceuticals | Adverum Biotechnologies vs. Solid Biosciences LLC |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Aroon Oscillator module to analyze current equity momentum using Aroon Oscillator and other momentum ratios.
Other Complementary Tools
| Idea Optimizer Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio | |
| Volatility Analysis Get historical volatility and risk analysis based on latest market data | |
| Equity Valuation Check real value of public entities based on technical and fundamental data | |
| Share Portfolio Track or share privately all of your investments from the convenience of any device | |
| Portfolio Suggestion Get suggestions outside of your existing asset allocation including your own model portfolios |